Matthew Thomas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Matthew Thomas has a total of 24 co-authors. Here are the top co-authors by number of shared publications:
Andrew Hollingsworth
Department of Vascular Surgery, James Cook University Hospital, Middlesbrough, UK
1 shared publicationClaire Dawkins
Department of Vascular Surgery; Freeman Hospital; Newcastle upon Tyne UK
1 shared publication- Colin H. Wilson
National Institute of Health and Care Research Blood and Transplant Research Unit, Newcastle University and Cambridge University, Newcastle upon Tyne, United Kingdom; Institute of Transplantation, Freeman Hospital, Newcastle upon Tyne, United Kingdom; Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, United Kingdom
1 shared publication Derek M. Manas
1 shared publicationErin Saricilar
Department of Vascular Surgery; Royal North Shore Hospital; Sydney Australia
1 shared publicationFaheez Mohamed
Basingstoke and North Hampshire Hospital Foundation Trust
1 shared publication
Latest Publications
- 7 January 2022
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2022 (1)
Antithrombotics after infra-inguinal peripheral endovascular treatment
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To determine the effects of antithrombotic agents compared with each other, with placebo, or with no treatment, in people with infra‐inguinal (below the anatomical level of the inguinal ligament) peripheral arterial disease who are undergoing peripheral endovascular treatment.
- 7 January 2022
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2022 (1)
Antithrombotics after infra-inguinal peripheral endovascular treatment
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To determine the effects of antithrombotic agents compared with each other, with placebo, or with no treatment, in people with infra‐inguinal (below the anatomical level of the inguinal ligament) peripheral arterial disease who are undergoing peripheral endovascular treatment.
- 23 December 2021
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2021 (12)
Antithrombotics after infra-inguinal bypass grafting
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To determine the effects of antithrombotic agents compared with each other, with placebo, or with no treatment, in people with peripheral arterial disease who are undergoing infra‐inguinal (below the anatomical level of the inguinal ligament) peripheral artery bypass surgery.
- 23 December 2021
- Published by Wiley in Cochrane Database of Systematic Reviews
- Vol. 2021 (12)
Antithrombotics after infra-inguinal bypass grafting
Objectives This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To determine the effects of antithrombotic agents compared with each other, with placebo, or with no treatment, in people with peripheral arterial disease who are undergoing infra‐inguinal (below the anatomical level of the inguinal ligament) peripheral artery bypass surgery.
- 1 July 2019
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 58, 363-370
Endovascular Management of Acute Lower Limb Deep Vein Thrombosis: A Systematic Review and Meta-analysis
- 1 July 2019
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 58, 363-370
Endovascular Management of Acute Lower Limb Deep Vein Thrombosis: A Systematic Review and Meta-analysis
- Open Access
- 16 March 2013
- Published by International Journal of Medical Education in International Journal of Medical Education
- Vol. 4, 48-58
The role of simulation in the development of technical competence during surgical training: a literature review
To establish the current state of knowledge on the effect of surgical simulation on the development of technical competence during surgical training.
- 16 March 2013
- Published by International Journal of Medical Education in International Journal of Medical Education
- Vol. 4, 48-58
Open AccessThe role of simulation in the development of technical competence during surgical training: a literature review
To establish the current state of knowledge on the effect of surgical simulation on the development of technical competence during surgical training.
- 1 April 2012
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 10 (2) , 168-171
Endoscopic Botulinum Toxin Injection for the Treatment of Diabetic Gastropathy in Pancreas and Islet-cell Transplant Patients
Gastroparesis is a well-recognized, long-term complication of diabetes. Prokinetic drugs are often not effective, prompting the development of alternative therapies. We report our experience of using one such alternative, endoscopic botulinum toxin injection, to ameliorate diabetic gastropathy in association with pancreas and islet-cell transplant patients. Three male diabetic patients aged 42 to 55 years had been treated with botulinum toxin in our center. Two patients were both after-simultaneous pancreas-kidney transplant and 1 was awaiting islet-cell transplant after pancreatectomy. Mechanical gastric outlet obstruction was first excluded by radiological and endoscopic studies. Between 100 and 200 IU of toxin were then injected in the prepyloric region using an endoscopic technique. A subjective scoring scale was used to assess symptoms before and after botulinum therapy. Improvement in subjective symptom severity scoring was seen in all patients, with a posttreatment improvement from 55% to 91%. Such improvement was temporary in 2 patients and long-lasting in 1 patient. The time for improvement of gastric autonomic function after pancreas or islet-cell transplantation remains unclear. Some patients may continue to be symptomatic, leading to increasing morbidity. However, endoscopic botulinum injections may provide short-term relief while waiting for improvement and spare patients the morbidity associated with more-invasive therapies.
- 1 April 2012
- Published by Baskent University in Experimental and Clinical Transplantation
- Vol. 10 (2) , 168-171
Endoscopic Botulinum Toxin Injection for the Treatment of Diabetic Gastropathy in Pancreas and Islet-cell Transplant Patients
Gastroparesis is a well-recognized, long-term complication of diabetes. Prokinetic drugs are often not effective, prompting the development of alternative therapies. We report our experience of using one such alternative, endoscopic botulinum toxin injection, to ameliorate diabetic gastropathy in association with pancreas and islet-cell transplant patients. Three male diabetic patients aged 42 to 55 years had been treated with botulinum toxin in our center. Two patients were both after-simultaneous pancreas-kidney transplant and 1 was awaiting islet-cell transplant after pancreatectomy. Mechanical gastric outlet obstruction was first excluded by radiological and endoscopic studies. Between 100 and 200 IU of toxin were then injected in the prepyloric region using an endoscopic technique. A subjective scoring scale was used to assess symptoms before and after botulinum therapy. Improvement in subjective symptom severity scoring was seen in all patients, with a posttreatment improvement from 55% to 91%. Such improvement was temporary in 2 patients and long-lasting in 1 patient. The time for improvement of gastric autonomic function after pancreas or islet-cell transplantation remains unclear. Some patients may continue to be symptomatic, leading to increasing morbidity. However, endoscopic botulinum injections may provide short-term relief while waiting for improvement and spare patients the morbidity associated with more-invasive therapies.
- 9 November 2011
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 27 (3) , 309-317
Dukes C colorectal cancer: is the metastatic lymph node ratio important?
Although the regional lymph node status is essential for staging of colorectal cancer, the importance of the total number of collected nodes remains controversial. Our aim was to examine the impact of the metastatic lymph node ratio (LNR) on the survival of patients with Dukes C colorectal cancer.
- 9 November 2011
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 27 (3) , 309-317
Dukes C colorectal cancer: is the metastatic lymph node ratio important?
Although the regional lymph node status is essential for staging of colorectal cancer, the importance of the total number of collected nodes remains controversial. Our aim was to examine the impact of the metastatic lymph node ratio (LNR) on the survival of patients with Dukes C colorectal cancer.
- 1 November 2011
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 20 (11) , 528-533
Manuka honey as an effective treatment for chronic pilonidal sinus wounds
Objective: A retrospective study to investigate the effectiveness of topical manuka honey in the treatment of chronic or recurrent pilonidal sinus disease (PSD), assessing the ability of this simple dressing technique to achieve complete wound healing, the time taken to achieve healing and the recurrence rate. Method: All patients who received manuka honey dressing therapy following surgical intervention for chronic or recurrent PSD were identified over a 4-year period. In a retrospective review of case notes, data were collected on patient sex, age, nature of surgical procedures performed, time to achieve complete wound healing, and recurrences after completion of honey therapy. Results: Seventeen patients were eligible for inclusion in the study. Mean time to commence honey therapy post-surgery was 93 days (5–517 days; median 33 days); 15 patients achieved complete wound healing, in a mean time of 65 days (14–264 days; median 49 days). Honey was discontinued in one patient due to an adverse event, and two patients experienced recurrence several months after completing honey therapy. Conclusion: Manuka honey dressing therapy provides an effective topical treatment for chronic/recurrent PSD. Further research is necessary to determine the optimum dressing protocol. Declaration of interest: The authors have no conflicts of interest to declare. There were no external sources of funding for this study.
- 1 November 2011
- Published by Mark Allen Group in Journal of Wound Care
- Vol. 20 (11) , 528-533
Manuka honey as an effective treatment for chronic pilonidal sinus wounds
Objective: A retrospective study to investigate the effectiveness of topical manuka honey in the treatment of chronic or recurrent pilonidal sinus disease (PSD), assessing the ability of this simple dressing technique to achieve complete wound healing, the time taken to achieve healing and the recurrence rate. Method: All patients who received manuka honey dressing therapy following surgical intervention for chronic or recurrent PSD were identified over a 4-year period. In a retrospective review of case notes, data were collected on patient sex, age, nature of surgical procedures performed, time to achieve complete wound healing, and recurrences after completion of honey therapy. Results: Seventeen patients were eligible for inclusion in the study. Mean time to commence honey therapy post-surgery was 93 days (5–517 days; median 33 days); 15 patients achieved complete wound healing, in a mean time of 65 days (14–264 days; median 49 days). Honey was discontinued in one patient due to an adverse event, and two patients experienced recurrence several months after completing honey therapy. Conclusion: Manuka honey dressing therapy provides an effective topical treatment for chronic/recurrent PSD. Further research is necessary to determine the optimum dressing protocol. Declaration of interest: The authors have no conflicts of interest to declare. There were no external sources of funding for this study.